Mirae Asset Global ETFs Holdings’s ClearPoint Neuro CLPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$114K Buy
12,512
+306
+3% +$3.86K ﹤0.01% 2606
2025
Q4
$167K Sell
12,206
-7
-0.1% -$130 ﹤0.01% 2433
2025
Q3
$266K Sell
12,213
-2,050
-14% -$24.1K ﹤0.01% 2169
2025
Q2
$170K Buy
+14,263
New +$179K ﹤0.01% 2364
2024
Q3
Sell
-11,389
Closed -$61.4K 3094
2024
Q2
$61.4K Buy
+11,389
New +$65.9K ﹤0.01% 2737

Other funds holding CLPT

Mirae Asset Global ETFs Holdings's CLPT Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its ClearPoint Neuro (CLPT) stake by 2.5% in Q1 2026, buying an estimated $3.86K and bringing the position to 12,512 shares worth $114K. The position accounts for ﹤0.01% of the portfolio, ranked #2606.

Mirae Asset Global ETFs Holdings first reported a position in CLPT in Q2 2024 and has held it in 5 quarters since. The position peaked at $266K in Q3 2025. 118 funds tracked by Wall St. Rank hold CLPT as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 12,512 shares of ClearPoint Neuro worth $114K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 306 ClearPoint Neuro shares in Q1 2026, an estimated $3.86K.
  • ClearPoint Neuro made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2606 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in ClearPoint Neuro in Q2 2024 and has held it in 5 quarters since.
  • Mirae Asset Global ETFs Holdings's ClearPoint Neuro position peaked at $266K in Q3 2025.
  • 118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.